DEPRESSION AND SELF-MANAGEMENT BEHAVIORS OF PATIENTS WITH T2DM AND STAGE 3 CKD

被引:0
|
作者
Sakraida, Teresa J. [1 ]
Terada, Masako [1 ]
Carron, Rebecca C. [1 ]
机构
[1] Univ Colorado Denver, Coll Nursing, Aurora, CO 80045 USA
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:140 / 140
页数:1
相关论文
共 50 条
  • [1] The Relationship Between Depressive Symptoms and Self-Management Behaviors in Patients With T2DM and Stage 3 CKD
    Sakraida, Teresa J.
    Weber, Mary T.
    [J]. PERSPECTIVES IN PSYCHIATRIC CARE, 2016, 52 (04) : 273 - 282
  • [2] Self-Care and Self-Management Among Adolescent T2DM Patients: A Review
    Eva, Jafrin Jahan
    Kassab, Yaman Walid
    Neoh, Chin Fen
    Ming, Long Chiau
    Wong, Yuet Yen
    Hameed, Mohammed Abdul
    Hong, Yet Hoi
    Sarker, Md Moklesur Rahman
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [3] Personality, Self-Management Behaviors, and Glycemic Control among Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
    Morikawa, Sakiko Y.
    Fujihara, Kazuya
    Hatta, Mariko
    Takeda, Yasunaga
    Ishii, Dai
    Yachida, Junko
    Horikawa, Chika
    Kato, Mitsutoshi
    Maegawa, Hiroshi
    Sone, Hirohito
    [J]. DIABETES, 2019, 68
  • [4] Understanding Diabetes Self-Management: Thai Buddhists With T2DM
    Wattanakul, Boontuan
    Quinn, Laurie
    Ruggiero, Laurie
    Finnegan, Lorna
    Zerwic, Julie
    Ferrans, Carol
    Patel, Minu
    [J]. DIABETES, 2012, 61 : A205 - A205
  • [5] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Sorensen, Charlotte M.
    Holst, Jens J.
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (11) : 659 - 660
  • [6] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Charlotte M. Sorensen
    Jens J. Holst
    [J]. Nature Reviews Nephrology, 2018, 14 : 659 - 660
  • [7] Risk of metformin use in patients with T2DM and advanced CKD
    Guntram Schernthaner
    Marie Helene Schernthaner-Reiter
    [J]. Nature Reviews Endocrinology, 2015, 11 : 697 - 699
  • [8] T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
    Thummasorn, Savitree
    Apichai, Sopida
    Chupradit, Supat
    Sirisattayawong, Pornpen
    Chaiwong, Pachpilai
    Sriwichaiin, Sirawit
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    [J]. PLOS ONE, 2022, 17 (08):
  • [9] CV benefits of finerenone in T2DM and CKD
    Huynh K.
    [J]. Nature Reviews Cardiology, 2021, 18 (11) : 738 - 738
  • [10] Rationale for exercise in T2DM patients with depression and/or obesity
    Kavookjian, Jan
    [J]. DIABETES, 2008, 57 : A305 - A305